Squarepoint Ops LLC Takes $1.09 Million Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Squarepoint Ops LLC bought a new position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 27,404 shares of the company's stock, valued at approximately $1,087,000.

A number of other institutional investors also recently modified their holdings of ACHC. Lindbrook Capital LLC increased its holdings in Acadia Healthcare by 1,342.0% during the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company's stock worth $29,000 after purchasing an additional 671 shares in the last quarter. Blue Trust Inc. raised its holdings in shares of Acadia Healthcare by 69.4% in the fourth quarter. Blue Trust Inc. now owns 842 shares of the company's stock valued at $33,000 after purchasing an additional 345 shares during the last quarter. Nisa Investment Advisors LLC lifted its position in shares of Acadia Healthcare by 40.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock valued at $41,000 after purchasing an additional 301 shares in the last quarter. Signaturefd LLC boosted its holdings in Acadia Healthcare by 460.6% during the fourth quarter. Signaturefd LLC now owns 1,222 shares of the company's stock worth $48,000 after purchasing an additional 1,004 shares during the last quarter. Finally, Fifth Third Bancorp grew its position in Acadia Healthcare by 56.0% in the 4th quarter. Fifth Third Bancorp now owns 1,264 shares of the company's stock worth $50,000 after purchasing an additional 454 shares in the last quarter.

Acadia Healthcare Stock Performance

Acadia Healthcare stock traded up $0.80 during midday trading on Tuesday, reaching $22.43. The stock had a trading volume of 675,357 shares, compared to its average volume of 1,713,519. The firm has a market capitalization of $2.07 billion, a PE ratio of 7.35, a P/E/G ratio of 1.46 and a beta of 1.01. Acadia Healthcare Company, Inc. has a 12 month low of $20.36 and a 12 month high of $82.41. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60. The firm's 50-day moving average price is $24.93 and its 200 day moving average price is $34.12.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last posted its quarterly earnings results on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.05. The company had revenue of $770.51 million for the quarter, compared to analyst estimates of $769.90 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The company's quarterly revenue was up .3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.84 earnings per share. As a group, research analysts predict that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on ACHC shares. Guggenheim initiated coverage on Acadia Healthcare in a research note on Wednesday, April 9th. They issued a "buy" rating and a $36.00 target price on the stock. Wall Street Zen raised Acadia Healthcare from a "sell" rating to a "hold" rating in a research report on Thursday, May 22nd. Bank of America reduced their price objective on Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating for the company in a research note on Friday, February 28th. Royal Bank of Canada lowered their target price on Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating on the stock in a research note on Monday, March 3rd. Finally, Barclays reduced their price target on shares of Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating for the company in a research report on Wednesday, May 14th. Four investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, Acadia Healthcare presently has a consensus rating of "Moderate Buy" and a consensus target price of $47.94.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.